메디호스피탈컨설팅

비상장계속사업자

Medihospital Consulting Co.,Ltd

김동철

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

메디호스피탈컨설팅

Business Reg. No. 2118892976 · CEO 김동철

I.Investment Overview

Target메디호스피탈컨설팅 (2118892976)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명메디호스피탈컨설팅
영문명Medihospital Consulting Co.,Ltd
대표자김동철
사업자등록번호2118892976
법인등록번호1101115093169
설립일2013.03.22

V.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW1.420211.12022120230.720240.62025
영업이익100M KRW-2.52021-0.72022-2.32023-7.7202402025
순이익100M KRW-5.42021-122022-14.12023-20.2202416.42025
Item20252024202320222021
자산총계644.9억원665.5억원590.9억원594.5억원620.4억원
부채총계2,160만원3,014만원2.4억원2.5억원2.7억원
자본총계644.7억원665.2억원588.5억원591.9억원617.7억원
매출액6,466만원7,238만원9,615만원1.1억원1.4억원
영업이익444만원-7.7억원-2.3억원-6,631만원-2.5억원
순이익16.4억원-20.2억원-14.1억원-12억원-5.4억원

VI.Financial Ratios

FY2025 basis

6.87%

영업이익률

2,538.82%

순이익률

2.55%

ROA

2.55%

ROE

0.03%

부채비율

99.97%

자기자본비율

VII.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

메디호스피탈컨설팅 투심보고서 | Alpha Lenz